To further provide clinical relevance, we analyzed a reported human GWAS dataset conducted in cancer patients who received doxorubicin therapy and identified two MAP7D1 gene variants associated with cardiac function decline and heart failure in humans. This evidence concerns the gene MAP7D1 and heart failure.